Delivery Order SPE2DB24D6039-SPE2DB24FLDXR
Award Date
8/12/24
Potential Completion Date
8/13/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,565,712,216 units of the pharmaceutical product Moxifloxacin HCl 400 mg Tablet UD 50s. The contract, valued at $7,576.84, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of September 9, 2024. This award is not associated with a set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,345.50 firm-fixed-price contract is for the delivery of 4,567,833,505 units of the drug moxifloxacin hydrochloride 400 mg tablets. The award has an ultimate completion date of April 9, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award is for the delivery of 4,567,320,273 units of the pharmaceutical product Moxifloxacin HCL 400 mg Tablet. The award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 20, 2025. The contract is a Delivery Order with a Firm Fixed Price of $2,691.00 and a completion date of February 21, 2025. The contract does not have a set-aside designation. Amerisourcebergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,345.50, is for the delivery of 4567606287 units of 400 mg Moxifloxacin HCL tablets. The contract has an ultimate completion date of March 19, 2025 and was awarded on March 18, 2025. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of 4,568,294,192 units of the pharmaceutical product Moxifloxacin HCL 400 mg Tablet. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $17,457.69 and a performance period ending on May 20, 2025. The contract is not set aside and allows for open competition. Amerisourcebergen Drug...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,824.02 delivery order contract is for the supply of 4,563,893,560 units of Moxifloxacin HCL 400 mg Tablets in 50-count units. The contract has a firm fixed price and a completion date of March 8, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for the supply of 4,563,943,915 units of the medication moxifloxacin hydrochloride 400 mg tablets. The contract has a completion date of March 13, 2024 and a ceiling value of $1,702.23....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the delivery of 4,565,454 moxifloxacin hydrochloride 400 milligram tablets. The Firm Fixed Price contract, valued at $24,219.36, has an ultimate completion date of August 15, 2024. This is a delivery order contract and does not utilize a set-aside designation. Amerisourcebergen, through its Corporate Office Division, has been awarded numerous...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,555.04, is for the delivery of 4567437079 - Moxifloxacin HCL 400 mg Tablet UD 50s, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 4, 2025. The contract is not designated with a set-aside....
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,345.50 firm fixed-price delivery order is for the supply of 4,564,783,446 units of the antibiotic medication moxifloxacin hydrochloride 400 mg tablets. The contract has a completion date of June 4, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...